Peroxisome proliferator-activated receptor alpha

<p>This section provides any useful information about the protein, mostly biological knowledge.<p><a href='/help/function_section' target='_top'>More...</a></p>Functionⁱ

Sites

Regions

<p>The <a href="http://www.geneontology.org/">Gene Ontology (GO)</a> project provides a set of hierarchical controlled vocabulary split into 3 categories:<p><a href='/help/gene_ontology' target='_top'>More...</a></p>GO - Molecular functionⁱ

• DNA-binding transcription activator activity, RNA polymerase II-specific Source: RGD
• DNA-binding transcription factor activity Source: RGD
• DNA-binding transcription factor binding Source: RGD
• DNA-binding transcription repressor activity, RNA polymerase II-specific Source: RGD
• lipid binding Source: UniProtKB
• MDM2/MDM4 family protein binding Source: RGD <p>Inferred from Physical Interaction</p> <p>Covers physical interactions between the gene product of interest and another molecule (or ion, or complex).</p> <p>More information in the <a href="http://geneontology.org/page/guide-go-evidence-codes#ipi">GO evidence code guide</a></p> Inferred from physical interactionⁱ
  • "Regulation of peroxisome proliferator-activated receptor-alpha by MDM2."
    Gopinathan L., Hannon D.B., Peters J.M., Vanden Heuvel J.P.
    Toxicol Sci 108:48-58(2009) [PubMed] [Europe PMC] [Abstract]
• NFAT protein binding Source: RGDInferred from physical interactionⁱ
  • "PPARalpha activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4."
    Le K., Li R., Xu S., Wu X., Huang H., Bao Y., Cai Y., Lan T., Moss J., Li C., Zou J., Shen X., Liu P.
    Arch Biochem Biophys 518:71-78(2012) [PubMed] [Europe PMC] [Abstract]
• nuclear receptor activity Source: RGD <p>Inferred from Mutant Phenotype</p> <p>Describes annotations that are concluded from looking at variations or changes in a gene product such as mutations or abnormal levels and includes techniques such as knockouts, overexpression, anti-sense experiments and use of specific protein inhibitors.</p> <p>More information in the <a href="http://geneontology.org/page/guide-go-evidence-codes#imp">GO evidence code guide</a></p> Inferred from mutant phenotypeⁱ
  • "Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha-interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator."
    Surapureddi S., Yu S., Bu H., Hashimoto T., Yeldandi A.V., Kashireddy P., Cherkaoui-Malki M., Qi C., Zhu Y.-J., Rao M.S., Reddy J.K.
    Proc. Natl. Acad. Sci. U.S.A. 99:11836-11841(2002) [PubMed] [Europe PMC] [Abstract]
  • "Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation."
    Gardner O.S., Dewar B.J., Earp H.S., Samet J.M., Graves L.M.
    J Biol Chem 278:46261-46269(2003) [PubMed] [Europe PMC] [Abstract]
• phosphatase binding Source: RGDInferred from physical interactionⁱ
  • "Cloning and identification of rat deoxyuridine triphosphatase as an inhibitor of peroxisome proliferator-activated receptor alpha."
    Chu R.Y., Lin Y.L., Rao M.S., Reddy J.K.
    J. Biol. Chem. 271:27670-27676(1996) [PubMed] [Europe PMC] [Abstract]
• protein-containing complex binding Source: RGDInferred from mutant phenotypeⁱ
  • "Histone acetylation and steroid receptor coactivator expression during clofibrate-induced rat hepatocarcinogenesis."
    Asano J., Kudo T., Shimizu T., Fan Y., Nanashima N., Yamana D., Miura T., Yamada T., Tsuchida S.
    Cancer Sci 101:869-875(2010) [PubMed] [Europe PMC] [Abstract]
• protein domain specific binding Source: RGD <p>Inferred from Direct Assay</p> <p>Used to indicate a direct assay for the function, process or component indicated by the GO term.</p> <p>More information in the <a href="http://geneontology.org/page/guide-go-evidence-codes#ida">GO evidence code guide</a></p> Inferred from direct assayⁱ
  • "Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha-interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator."
    Surapureddi S., Yu S., Bu H., Hashimoto T., Yeldandi A.V., Kashireddy P., Cherkaoui-Malki M., Qi C., Zhu Y.-J., Rao M.S., Reddy J.K.
    Proc. Natl. Acad. Sci. U.S.A. 99:11836-11841(2002) [PubMed] [Europe PMC] [Abstract]
• RNA polymerase II cis-regulatory region sequence-specific DNA binding Source: RGD
• RNA polymerase II-specific DNA-binding transcription factor binding Source: RGD
• sequence-specific DNA binding Source: RGDInferred from direct assayⁱ
  • "The ribosomal protein rpL11 associates with and inhibits the transcriptional activity of peroxisome proliferator-activated receptor-alpha."
    Gray J.P., Davis J.W., Gopinathan L., Leas T.L., Nugent C.A., Vanden Heuvel J.P.
    Toxicol Sci 89:535-546(2006) [PubMed] [Europe PMC] [Abstract]
• signaling receptor activity Source: RGD
• steroid hormone receptor activity Source: RGD
• transcription coactivator binding Source: RGDInferred from physical interactionⁱ
  • "omega-6 lipids regulate PPAR turnover via reciprocal switch between PGC-1 alpha and ubiquitination."
    Fei J., Cook C., Santanam N.
    Atherosclerosis 222:395-401(2012) [PubMed] [Europe PMC] [Abstract]
• ubiquitin conjugating enzyme binding Source: RGD
• zinc ion binding Source: InterPro

GO - Biological processⁱ

• behavioral response to nicotine Source: RGDInferred from direct assayⁱ
  • "Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors."
    Mascia P., Pistis M., Justinova Z., Panlilio L.V., Luchicchi A., Lecca S., Scherma M., Fratta W., Fadda P., Barnes C., Redhi G.H., Yasar S., Le Foll B., Tanda G., Piomelli D., Goldberg S.R.
    Biol Psychiatry 69:633-641(2011) [PubMed] [Europe PMC] [Abstract]
• cell differentiation Source: GO_Central <p>Inferred from Biological aspect of Ancestor</p> <p>A type of phylogenetic evidence whereby an aspect of a descendent is inferred through the characterization of an aspect of a ancestral gene.</p> <p>More information in the <a href="http://geneontology.org/page/guide-go-evidence-codes#iba">GO evidence code guide</a></p> Inferred from biological aspect of ancestorⁱ
  • "Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium."
    Gaudet P., Livstone M.S., Lewis S.E., Thomas P.D.
    Brief Bioinform 12:449-462(2011) [PubMed] [Europe PMC] [Abstract]
• cellular response to starvation Source: RGD
• circadian regulation of gene expression Source: UniProtKB
• enamel mineralization Source: RGD
• epidermis development Source: RGD
• fatty acid metabolic process Source: RGDInferred from mutant phenotypeⁱ
  • "Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism."
    Gilde A.J., van der Lee K.A., Willemsen P.H., Chinetti G., van der Leij F.R., van der Vusse G.J., Staels B., van Bilsen M.
    Circ Res 92:518-524(2003) [PubMed] [Europe PMC] [Abstract]
  • "Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor alpha activity in rat primary hepatocytes."
    Pawar A., Jump D.B.
    J Biol Chem 278:35931-35939(2003) [PubMed] [Europe PMC] [Abstract]
  • "Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats."
    Oakes N.D., Thalen P., Hultstrand T., Jacinto S., Camejo G., Wallin B., Ljung B.
    Am J Physiol Regul Integr Comp Physiol 289:R938-46(2005) [PubMed] [Europe PMC] [Abstract]
• heart development Source: RGD <p>Inferred from Expression Pattern</p> <p>Covers cases where the annotation is inferred from the timing or location of expression of a gene.</p> <p>More information in the <a href="http://geneontology.org/page/guide-go-evidence-codes#iep">GO evidence code guide</a></p> Inferred from expression patternⁱ
  • "Changes in expression levels of genes involved in fatty acid metabolism: upregulation of all three members of the PPAR family (alpha, gamma, delta) and the newly described adiponectin receptor 2, but not adiponectin receptor 1 during neonatal cardiac development of the rat."
    Steinmetz M., Quentin T., Poppe A., Paul T., Jux C.
    Basic Res Cardiol 100:263-269(2005) [PubMed] [Europe PMC] [Abstract]
• hormone-mediated signaling pathway Source: GO_CentralInferred from biological aspect of ancestorⁱ
  • "Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium."
    Gaudet P., Livstone M.S., Lewis S.E., Thomas P.D.
    Brief Bioinform 12:449-462(2011) [PubMed] [Europe PMC] [Abstract]
• lipid localization Source: RGDInferred from expression patternⁱ
  • "Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner."
    Xu W., Lu C., Yao L., Zhang F., Shao J., Zheng S.
    Toxicol Appl Pharmacol 315:23-34(2017) [PubMed] [Europe PMC] [Abstract]
• lipoprotein metabolic process Source: RGDInferred from mutant phenotypeⁱ
  • "Activation of peroxisome proliferator-activated receptor alpha increases the expression and activity of microsomal triglyceride transfer protein in the liver."
    Ameen C., Edvardsson U., Ljungberg A., Asp L., Akerblad P., Tuneld A., Olofsson S.O., Linden D., Oscarsson J.
    J Biol Chem 280:1224-1229(2005) [PubMed] [Europe PMC] [Abstract]
• negative regulation of appetite Source: UniProtKB
• negative regulation of blood pressure Source: RGDInferred from mutant phenotypeⁱ
  • "Peroxisome proliferator-activated receptor-alpha activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade."
    Williams J.M., Zhao X., Wang M.H., Imig J.D., Pollock D.M.
    Hypertension 46:366-371(2005) [PubMed] [Europe PMC] [Abstract]
• negative regulation of cell growth involved in cardiac muscle cell development Source: RGDInferred from mutant phenotypeⁱ
  • "PPARalpha activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4."
    Le K., Li R., Xu S., Wu X., Huang H., Bao Y., Cai Y., Lan T., Moss J., Li C., Zou J., Shen X., Liu P.
    Arch Biochem Biophys 518:71-78(2012) [PubMed] [Europe PMC] [Abstract]
• negative regulation of cholesterol storage Source: RGD
• negative regulation of cytokine production involved in inflammatory response Source: RGD
• negative regulation of glycolytic process Source: RGD
• negative regulation of hepatocyte apoptotic process Source: RGD
• negative regulation of inflammatory response Source: RGD
• negative regulation of leukocyte cell-cell adhesion Source: RGD
• negative regulation of macrophage derived foam cell differentiation Source: RGD
• negative regulation of miRNA transcription Source: RGD
• negative regulation of neuron death Source: RGDInferred from direct assayⁱ
  • "Peroxisome proliferator-activated receptor-alpha agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function."
    Gray E., Ginty M., Kemp K., Scolding N., Wilkins A.
    Eur J Neurosci 33:1421-1432(2011) [PubMed] [Europe PMC] [Abstract]
• negative regulation of protein binding Source: RGDInferred from mutant phenotypeⁱ
  • "PPARalpha activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4."
    Le K., Li R., Xu S., Wu X., Huang H., Bao Y., Cai Y., Lan T., Moss J., Li C., Zou J., Shen X., Liu P.
    Arch Biochem Biophys 518:71-78(2012) [PubMed] [Europe PMC] [Abstract]
• negative regulation of protein kinase B signaling Source: RGD
• negative regulation of reactive oxygen species biosynthetic process Source: RGD
• negative regulation of sequestering of triglyceride Source: RGD
• negative regulation of signaling receptor activity Source: RGD
• negative regulation of transcription by RNA polymerase II Source: RGD
• negative regulation of transforming growth factor beta receptor signaling pathway Source: RGD
• positive regulation of ATP biosynthetic process Source: RGD
• positive regulation of fatty acid metabolic process Source: GO_CentralInferred from biological aspect of ancestorⁱ
  • "Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium."
    Gaudet P., Livstone M.S., Lewis S.E., Thomas P.D.
    Brief Bioinform 12:449-462(2011) [PubMed] [Europe PMC] [Abstract]
• positive regulation of fatty acid oxidation Source: RGD
• positive regulation of gluconeogenesis Source: RGD
• positive regulation of lipid biosynthetic process Source: RGD
• positive regulation of transcription, DNA-templated Source: UniProtKB
• positive regulation of transcription by RNA polymerase II Source: RGD
• positive regulation of viral genome replication Source: RGD
• regulation of cellular ketone metabolic process Source: RGD
• regulation of circadian rhythm Source: UniProtKB
• regulation of fatty acid metabolic process Source: RGD
• regulation of gene expression Source: RGD
• regulation of lipid metabolic process Source: GO_CentralInferred from biological aspect of ancestorⁱ
  • "Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium."
    Gaudet P., Livstone M.S., Lewis S.E., Thomas P.D.
    Brief Bioinform 12:449-462(2011) [PubMed] [Europe PMC] [Abstract]
• regulation of lipid storage Source: RGDInferred from expression patternⁱ
  • "Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner."
    Xu W., Lu C., Yao L., Zhang F., Shao J., Zheng S.
    Toxicol Appl Pharmacol 315:23-34(2017) [PubMed] [Europe PMC] [Abstract]
• regulation of transcription, DNA-templated Source: RGDInferred from direct assayⁱ
  • "Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha-interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator."
    Surapureddi S., Yu S., Bu H., Hashimoto T., Yeldandi A.V., Kashireddy P., Cherkaoui-Malki M., Qi C., Zhu Y.-J., Rao M.S., Reddy J.K.
    Proc. Natl. Acad. Sci. U.S.A. 99:11836-11841(2002) [PubMed] [Europe PMC] [Abstract]
• response to ethanol Source: RGDInferred from expression patternⁱ
  • "Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner."
    Xu W., Lu C., Yao L., Zhang F., Shao J., Zheng S.
    Toxicol Appl Pharmacol 315:23-34(2017) [PubMed] [Europe PMC] [Abstract]
• response to hypoxia Source: HGNC-UCLInferred from direct assayⁱ
  • "Evidence for mitochondrial thioesterase 1 as a peroxisome proliferator-activated receptor-alpha-regulated gene in cardiac and skeletal muscle."
    Stavinoha M.A., RaySpellicy J.W., Essop M.F., Graveleau C., Abel E.D., Hart-Sailors M.L., Mersmann H.J., Bray M.S., Young M.E.
    Am J Physiol Endocrinol Metab 287:E888-95(2004) [PubMed] [Europe PMC] [Abstract]
• response to insulin Source: RGDInferred from mutant phenotypeⁱ
  • "Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats."
    Oakes N.D., Thalen P., Hultstrand T., Jacinto S., Camejo G., Wallin B., Ljung B.
    Am J Physiol Regul Integr Comp Physiol 289:R938-46(2005) [PubMed] [Europe PMC] [Abstract]
• response to lipid Source: GO_CentralInferred from biological aspect of ancestorⁱ
  • "Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium."
    Gaudet P., Livstone M.S., Lewis S.E., Thomas P.D.
    Brief Bioinform 12:449-462(2011) [PubMed] [Europe PMC] [Abstract]
• response to organic cyclic compound Source: RGDInferred from expression patternⁱ
  • "Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner."
    Xu W., Lu C., Yao L., Zhang F., Shao J., Zheng S.
    Toxicol Appl Pharmacol 315:23-34(2017) [PubMed] [Europe PMC] [Abstract]
• wound healing Source: RGD

<p>UniProtKB Keywords constitute a <a href="http://www.uniprot.org/keywords">controlled vocabulary</a> with a hierarchical structure. Keywords summarise the content of a UniProtKB entry and facilitate the search for proteins of interest.<p><a href='/help/keywords' target='_top'>More...</a></p>Keywordsⁱ

Enzyme and pathway databases

<p>This section provides information about the protein and gene name(s) and synonym(s) and about the organism that is the source of the protein sequence.<p><a href='/help/names_and_taxonomy_section' target='_top'>More...</a></p>Names & Taxonomyⁱ

Organism-specific databases

<p>This section provides information on the location and the topology of the mature protein in the cell.<p><a href='/help/subcellular_location_section' target='_top'>More...</a></p>Subcellular locationⁱ

• UniProt annotation
• GO - Cellular component

Keywords - Cellular componentⁱ

<p>This section provides information on the disease(s) and phenotype(s) associated with a protein.<p><a href='/help/pathology_and_biotech_section' target='_top'>More...</a></p>Pathology & Biotechⁱ

Chemistry databases

<p>This section describes post-translational modifications (PTMs) and/or processing events.<p><a href='/help/ptm_processing_section' target='_top'>More...</a></p>PTM / Processingⁱ

Molecule processing

<p>This subsection of the <a href="http://www.uniprot.org/help/ptm%5Fprocessing%5Fsection">PTM/processing</a> section describes post-translational modifications (PTMs). This subsection <strong>complements</strong> the information provided at the sequence level or describes modifications for which <strong>position-specific data is not yet available</strong>.<p><a href='/help/post-translational_modification' target='_top'>More...</a></p>Post-translational modificationⁱ

Keywords - PTMⁱ

Proteomic databases

PTM databases

<p>This section provides information on the expression of a gene at the mRNA or protein level in cells or in tissues of multicellular organisms.<p><a href='/help/expression_section' target='_top'>More...</a></p>Expressionⁱ

<p>This subsection of the 'Expression' section provides information on the expression of a gene at the mRNA or protein level in cells or in tissues of multicellular organisms. By default, the information is derived from experiments at the mRNA level, unless specified 'at protein level'.<br></br>Examples: <a href="http://www.uniprot.org/uniprot/P92958#expression">P92958</a>, <a href="http://www.uniprot.org/uniprot/Q8TDN4#expression">Q8TDN4</a>, <a href="http://www.uniprot.org/uniprot/O14734#expression">O14734</a><p><a href='/help/tissue_specificity' target='_top'>More...</a></p>Tissue specificityⁱ

Gene expression databases

<p>This section provides information on the quaternary structure of a protein and on interaction(s) with other proteins or protein complexes.<p><a href='/help/interaction_section' target='_top'>More...</a></p>Interactionⁱ

<p>This subsection of the <a href="http://www.uniprot.org/help/interaction%5Fsection">'Interaction'</a> section provides information about the protein quaternary structure and interaction(s) with other proteins or protein complexes (with the exception of physiological receptor-ligand interactions which are annotated in the <a href="http://www.uniprot.org/help/function%5Fsection">'Function'</a> section).<p><a href='/help/subunit_structure' target='_top'>More...</a></p>Subunit structureⁱ

<p>This subsection of the '<a href="http://www.uniprot.org/help/interaction%5Fsection">Interaction</a>' section provides information about binary protein-protein interactions. The data presented in this section are a quality-filtered subset of binary interactions automatically derived from the <a href="https://www.ebi.ac.uk/intact/">IntAct database</a>. It is updated at every <a href="http://www.uniprot.org/help/synchronization">UniProt release</a>.<p><a href='/help/binary_interactions' target='_top'>More...</a></p>Binary interactionsⁱ

GO - Molecular functionⁱ

• DNA-binding transcription factor binding Source: RGD
• MDM2/MDM4 family protein binding Source: RGDInferred from physical interactionⁱ
  • "Regulation of peroxisome proliferator-activated receptor-alpha by MDM2."
    Gopinathan L., Hannon D.B., Peters J.M., Vanden Heuvel J.P.
    Toxicol Sci 108:48-58(2009) [PubMed] [Europe PMC] [Abstract]
• NFAT protein binding Source: RGDInferred from physical interactionⁱ
  • "PPARalpha activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4."
    Le K., Li R., Xu S., Wu X., Huang H., Bao Y., Cai Y., Lan T., Moss J., Li C., Zou J., Shen X., Liu P.
    Arch Biochem Biophys 518:71-78(2012) [PubMed] [Europe PMC] [Abstract]
• phosphatase binding Source: RGDInferred from physical interactionⁱ
  • "Cloning and identification of rat deoxyuridine triphosphatase as an inhibitor of peroxisome proliferator-activated receptor alpha."
    Chu R.Y., Lin Y.L., Rao M.S., Reddy J.K.
    J. Biol. Chem. 271:27670-27676(1996) [PubMed] [Europe PMC] [Abstract]
• protein domain specific binding Source: RGDInferred from direct assayⁱ
  • "Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha-interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator."
    Surapureddi S., Yu S., Bu H., Hashimoto T., Yeldandi A.V., Kashireddy P., Cherkaoui-Malki M., Qi C., Zhu Y.-J., Rao M.S., Reddy J.K.
    Proc. Natl. Acad. Sci. U.S.A. 99:11836-11841(2002) [PubMed] [Europe PMC] [Abstract]
• RNA polymerase II-specific DNA-binding transcription factor binding Source: RGD
• transcription coactivator binding Source: RGDInferred from physical interactionⁱ
  • "omega-6 lipids regulate PPAR turnover via reciprocal switch between PGC-1 alpha and ubiquitination."
    Fei J., Cook C., Santanam N.
    Atherosclerosis 222:395-401(2012) [PubMed] [Europe PMC] [Abstract]
• ubiquitin conjugating enzyme binding Source: RGD

Protein-protein interaction databases

Chemistry databases

<p>This section provides information on the tertiary and secondary structure of a protein.<p><a href='/help/structure_section' target='_top'>More...</a></p>Structureⁱ

3D structure databases

<p>This section provides information on sequence similarities with other proteins and the domain(s) present in a protein.<p><a href='/help/family_and_domains_section' target='_top'>More...</a></p>Family & Domainsⁱ

Domains and Repeats

Region

<p>This subsection of the 'Family and domains' section provides information about the sequence similarity with other proteins.<p><a href='/help/sequence_similarities' target='_top'>More...</a></p>Sequence similaritiesⁱ

Zinc finger

Keywords - Domainⁱ

Phylogenomic databases

Family and domain databases

<p>This section displays by default the canonical protein sequence and upon request all isoforms described in the entry. It also includes information pertinent to the sequence(s), including <a href="http://www.uniprot.org/help/sequence%5Flength">length</a> and <a href="http://www.uniprot.org/help/sequences">molecular weight</a>. The information is filed in different subsections. The current subsections and their content are listed below:<p><a href='/help/sequences_section' target='_top'>More...</a></p>Sequenceⁱ

<p>This subsection of the <a href="http://www.uniprot.org/help/sequences%5Fsection">Sequence</a> section indicates if the <a href="http://www.uniprot.org/help/canonical%5Fand%5Fisoforms">canonical sequence</a> displayed by default in the entry is complete or not.<p><a href='/help/sequence_status' target='_top'>More...</a></p>Sequence statusⁱ: Complete.

        10         20         30         40         50
MVDTESPICP LSPLEADDLE SPLSEEFLQE MGNIQEISQS LGEESSGSFS 
        60         70         80         90        100
FADYQYLGSC PGSEGSVITD TLSPASSPSS VSCPAVPTST DESPGNALNI 
       110        120        130        140        150
ECRICGDKAS GYHYGVHACE GCKGFFRRTI RLKLAYDKCD RSCKIQKKNR 
       160        170        180        190        200
NKCQYCRFHK CLSVGMSHNA IRFGRMPRSE KAKLKAEILT CEHDLKDSET 
       210        220        230        240        250
ADLKSLAKRI HEAYLKNFNM NKVKARVILA GKTSNNPPFV IHDMETLCMA 
       260        270        280        290        300
EKTLVAKMVA NGVENKEAEV RFFHCCQCMS VETVTELTEF AKAIPGFANL 
       310        320        330        340        350
DLNDQVTLLK YGVYEAIFTM LSSLMNKDGM LIAYGNGFIT REFLKNLRKP 
       360        370        380        390        400
FCDIMEPKFD FAMKFNALEL DDSDISLFVA AIICCGDRPG LLNIGYIEKL 
       410        420        430        440        450
QEGIVHVLKL HLQSNHPDDT FLFPKLLQKM VDLRQLVTEH AQLVQVIKKT 
       460 
ESDAALHPLL QEIYRDMY                                    

Sequence databases

Genome annotation databases

<p>This section provides links to proteins that are similar to the protein sequence(s) described in this entry at different levels of sequence identity thresholds (100%, 90% and 50%) based on their membership in UniProt Reference Clusters (<a href="http://www.uniprot.org/help/uniref">UniRef</a>).<p><a href='/help/similar_proteins_section' target='_top'>More...</a></p>Similar proteinsⁱ

• 100% Identity
• 90% Identity
• 50% Identity

<p>This section is used to point to information related to entries and found in data collections other than UniProtKB.<p><a href='/help/cross_references_section' target='_top'>More...</a></p>Cross-referencesⁱ

Sequence databases

3D structure databases

Protein-protein interaction databases

Chemistry databases

PTM databases

Proteomic databases

Genome annotation databases

Organism-specific databases

Phylogenomic databases

Enzyme and pathway databases

Miscellaneous databases

Gene expression databases

Family and domain databases

<p>This section provides general information on the entry.<p><a href='/help/entry_information_section' target='_top'>More...</a></p>Entry informationⁱ

<p>This section contains any relevant information that doesn't fit in any other defined sections<p><a href='/help/miscellaneous_section' target='_top'>More...</a></p>Miscellaneousⁱ

Keywords - Technical termⁱ

Documents

1. SIMILARITY comments
   Index of protein domains and families